Estimates Revisions Repligen Corporation
Stocks
RGEN
US7599161095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 147.06 USD | +4.29% |
|
+11.44% | -10.25% |
| 07-30 | Repligen's Diversity of Growth Drivers Support Return to Mid-Teens Organic Sales Growth, RBC Says | MT |
| 07-29 | RBC Raises Price Target on Repligen to $185 From $160, Keeps Outperform Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RGEN Stock
- Consensus Repligen Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
